KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Idexx Laboratories (IDXX) Net Margin (2016 - 2025)

Idexx Laboratories has reported Net Margin over the past 17 years, most recently at 22.76% for Q4 2025.

  • Quarterly results put Net Margin at 22.76% for Q4 2025, up 11.0% from a year ago — trailing twelve months through Dec 2025 was 24.62% (up 184.0% YoY), and the annual figure for FY2025 was 24.62%, up 184.0%.
  • Net Margin for Q4 2025 was 22.76% at Idexx Laboratories, down from 24.85% in the prior quarter.
  • Over the last five years, Net Margin for IDXX hit a ceiling of 26.5% in Q2 2025 and a floor of 15.34% in Q2 2022.
  • Median Net Margin over the past 5 years was 23.18% (2022), compared with a mean of 22.76%.
  • Biggest five-year swings in Net Margin: crashed -910bps in 2022 and later surged 843bps in 2023.
  • Idexx Laboratories' Net Margin stood at 20.32% in 2021, then grew by 2bps to 20.78% in 2022, then increased by 4bps to 21.58% in 2023, then rose by 5bps to 22.65% in 2024, then grew by 0bps to 22.76% in 2025.
  • The last three reported values for Net Margin were 22.76% (Q4 2025), 24.85% (Q3 2025), and 26.5% (Q2 2025) per Business Quant data.